FDA clears InterVene’s in-stent restenosis catheter

InterVene’s Recana is claimed to be the first fully integrated catheter system to address venous in-stent restenosis (ISR).

InterVene’s Recana, a mechanical thrombectomy catheter designed to address venous in-stent restenosis (ISR) and clear vessel obstructions, has received 510(k) clearance from the US Food and Drug Administration (FDA).

ISR, or the re-narrowing of a blood vessel, is most commonly seen in deep venous stent placement, particularly in patients with thrombotic pathology.

Sign up for Blog Updates